Serge Doan

3.2k total citations
114 papers, 1.9k citations indexed

About

Serge Doan is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Serge Doan has authored 114 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Public Health, Environmental and Occupational Health, 55 papers in Ophthalmology and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Serge Doan's work include Ocular Surface and Contact Lens (63 papers), Ocular Infections and Treatments (25 papers) and Corneal Surgery and Treatments (24 papers). Serge Doan is often cited by papers focused on Ocular Surface and Contact Lens (63 papers), Ocular Infections and Treatments (25 papers) and Corneal Surgery and Treatments (24 papers). Serge Doan collaborates with scholars based in France, Italy and Spain. Serge Doan's co-authors include Éric Gabison, Andrea Leonardi, I. Cochereau, T. Hoang–Xuan, Christophe Baudouin, Luís Delgado, Frédéric Chiambaretta, Dominique Brémond‐Gignac, Damien Gatinel and Monika Jędrzejczak-Czechowicz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal Of Pathology.

In The Last Decade

Serge Doan

106 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serge Doan France 26 1.0k 764 536 455 339 114 1.9k
Alejandro Rodríguez-García Mexico 20 316 0.3× 1.1k 1.4× 236 0.4× 39 0.1× 105 0.3× 112 1.7k
María Teresa Rodríguez Ares Spain 20 846 0.8× 608 0.8× 754 1.4× 179 0.4× 142 0.4× 56 1.4k
Richard A. Eiferman United States 23 579 0.6× 715 0.9× 679 1.3× 88 0.2× 113 0.3× 64 1.5k
Wolfgang Bernauer Switzerland 18 341 0.3× 353 0.5× 231 0.4× 26 0.1× 40 0.1× 48 876
Sunay Duman Türkiye 25 404 0.4× 1.5k 2.0× 1.0k 1.9× 20 0.0× 91 0.3× 119 2.0k
Alejandro Navas Mexico 18 490 0.5× 652 0.9× 832 1.6× 40 0.1× 47 0.1× 103 1.2k
Timothy D. Blalock United States 17 283 0.3× 221 0.3× 420 0.8× 42 0.1× 80 0.2× 20 1.2k
A H Rahi Mexico 20 197 0.2× 607 0.8× 487 0.9× 60 0.1× 26 0.1× 61 1.2k
Bhaskar Srinivasan India 20 627 0.6× 448 0.6× 718 1.3× 35 0.1× 102 0.3× 95 1.2k
Y Pouliquen France 17 373 0.4× 637 0.8× 767 1.4× 25 0.1× 73 0.2× 200 1.2k

Countries citing papers authored by Serge Doan

Since Specialization
Citations

This map shows the geographic impact of Serge Doan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Doan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Doan more than expected).

Fields of papers citing papers by Serge Doan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Doan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Doan. The network helps show where Serge Doan may publish in the future.

Co-authorship network of co-authors of Serge Doan

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Doan. A scholar is included among the top collaborators of Serge Doan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Doan. Serge Doan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mageau, Arthur, Serge Doan, Isabelle Klein, et al.. (2024). Risk factors for severe hearing loss in Susac syndrome: A national cohort study. European Journal of Neurology. 31(5). e16211–e16211. 6 indexed citations
2.
Doan, Serge, Nikolaos G. Papadopoulos, Jason K. Lee, et al.. (2023). Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab. World Allergy Organization Journal. 16(6). 100788–100788. 7 indexed citations
3.
Doan, Serge, et al.. (2023). Severe Corneal Involvement Associated With Mpox Infection. JAMA Ophthalmology. 141(4). 402–402. 6 indexed citations
4.
Leonardi, Andrea, Pierre‐Jean Pisella, J.M. Benítez-del-Castillo, et al.. (2023). NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis. Clinical Therapeutics. 45(12). 1284–1288. 4 indexed citations
5.
Doan, Serge, Laurent Arnould, Pierre Fournié, et al.. (2022). Blépharo-conjonctivites sous dupilumab : recommandations du groupe CEDRE. Dermatite atopique, conjonctivites et dupilumab : quelle prise en charge ?. Journal Français d Ophtalmologie. 45(3). 277–287. 3 indexed citations
6.
Cohen‐Aubart, Fleur, Serge Doan, Éric Jouvent, et al.. (2021). Brain magnetic resonance imaging lesion load at diagnosis, severity at onset and outcomes in Susac syndrome: A prospective cohort study. European Journal of Neurology. 29(1). 121–129. 6 indexed citations
7.
Doan, Serge, Z Zagórski, Meltem Yağmur, et al.. (2020). Eyelid Disorders in Ophthalmology Practice: Results from a Large International Epidemiological Study in Eleven Countries. Ophthalmology and Therapy. 9(3). 597–608. 5 indexed citations
8.
Mahmoud, Anis, et al.. (2019). Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Brémond‐Gignac, Dominique, Pasquale Aragona, Serge Doan, et al.. (2019). Safety and Tolerability of Topical Cyclosporine A Cationic Emulsion in Patients With Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Pooled Results of the NOVATIVE and VEKTIS Trials. Investigative Ophthalmology & Visual Science. 60(9). 6710–6710. 1 indexed citations
10.
Abdelmassih, Youssef, Rana Saad, Damien Guindolet, et al.. (2019). Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes. The Ocular Surface. 18(2). 231–236. 64 indexed citations
11.
Rousseau, Antoine, C. Prost‐Squarcioni, Serge Doan, et al.. (2019). Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up. British Journal of Ophthalmology. 104(2). 235–240. 7 indexed citations
12.
Gabison, Éric, et al.. (2018). Epidemiology of neurotrophic keratitis: prevalence, etiologies, outcomes and clinical management. Investigative Ophthalmology & Visual Science. 59(9). 1800–1800. 2 indexed citations
13.
Leonardi, Andrea, Serge Doan, Mourad Amrane, et al.. (2017). Topical Ciclosporin A 1 mg/mL Cationic Emulsion in the Treatment of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study. Investigative Ophthalmology & Visual Science. 58(8). 541–541. 1 indexed citations
14.
Huet, E., Benoît Vallée, Jean Delbé, et al.. (2011). EMMPRIN Modulates Epithelial Barrier Function through a MMP–Mediated Occludin Cleavage. American Journal Of Pathology. 179(3). 1278–1286. 51 indexed citations
15.
Burrel, Sonia, Serge Doan, I. Cochereau, et al.. (2011). Acyclovir-Resistant Corneal HSV-1 Isolates From Two Immunocompetent Patients With Recurrent Herpetic Keratitis. Investigative Ophthalmology & Visual Science. 52(14). 5858–5858. 2 indexed citations
16.
Roux‐Villet, C. Le, Pascale Loiseau, Marc Busson, et al.. (2011). Black Patients of African Descent and HLA-DRB1*15:03 Frequency Overrepresented in Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 131(12). 2386–2393. 57 indexed citations
17.
Brémond‐Gignac, Dominique, Jean Donadieu, Andrea Leonardi, et al.. (2008). Prevalence of vernal keratoconjunctivitis: a rare disease?. British Journal of Ophthalmology. 92(8). 1097–1102. 91 indexed citations
18.
Doan, Serge, et al.. (2006). Rituximab in Severe Ocular Cicatricial Pemphigoid. Investigative Ophthalmology & Visual Science. 47(13). 594–594. 1 indexed citations
19.
Alexandre, M., Marie-Dominique Brette, Francis Pascal, et al.. (2006). A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid. Medicine. 85(4). 239–252. 42 indexed citations
20.
Messmer, Eli sa beth M., Jose Benitez-del-Castillo, Alessandro Lambìase, & Serge Doan. (2004). Neue Erkenntnisse zu Erkrankungen der Augenoberfl�che. Der Ophthalmologe. 102(3). 293–300. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Rodríguez-García Breakdown of academic impact, for papers by María Teresa Rodríguez Ares Breakdown of academic impact, for papers by Richard A. Eiferman Breakdown of academic impact, for papers by Wolfgang Bernauer Breakdown of academic impact, for papers by Sunay Duman Breakdown of academic impact, for papers by Alejandro Navas Breakdown of academic impact, for papers by Timothy D. Blalock Breakdown of academic impact, for papers by A H Rahi Breakdown of academic impact, for papers by Bhaskar Srinivasan Breakdown of academic impact, for papers by Y Pouliquen
Rankless by CCL
2026